Robot | Path | Permission |
GoogleBot | / | ✔ |
BingBot | / | ✔ |
BaiduSpider | / | ✔ |
YandexBot | / | ✔ |
User-agent: * Disallow: /404 Disallow: /thank-you Disallow: /thank-you-another-cancer Sitemap: https://www.lenvima.com/sitemap.xml |
Title | LENVIMA® |
Description | Your path forward with LENVIMA starts Learn about LENVIMA® (lenvatinib), a prescription medicine that may help treat people with certain kinds of |
Keywords | lenvima |
WebSite | lenvima.com |
Host IP | 208.74.145.245 |
Location | United States |
Site | Rank |
US$52,874,457
Last updated: 2022-06-17 12:59:56
lenvima.com has Semrush global rank of 200,178. lenvima.com has an estimated worth of US$ 52,874,457, based on its estimated Ads revenue. lenvima.com receives approximately 6,100,899 unique visitors each day. Its web server is located in United States, with IP address 208.74.145.245. According to SiteAdvisor, lenvima.com is safe to visit. |
Purchase/Sale Value | US$52,874,457 |
Daily Ads Revenue | US$48,808 |
Monthly Ads Revenue | US$1,464,216 |
Yearly Ads Revenue | US$17,570,589 |
Daily Unique Visitors | 406,727 |
Note: All traffic and earnings values are estimates. |
Host | Type | TTL | Data |
lenvima.com. | A | 10800 | IP: 208.74.145.245 |
lenvima.com. | NS | 10800 | NS Record: ns1.acompany.global. |
lenvima.com. | NS | 10800 | NS Record: ns3.acompany.global. |
lenvima.com. | NS | 10800 | NS Record: ns2.acompany.global. |
lenvima.com. | TXT | 10800 | TXT Record: v=spf1 -all |
LENVIMA® (lenvatinib) is a prescription medicine that is used to treat people with certain kinds of cancer. LENVIMA is used by itself to treat differentiated thyroid cancer (DTC) , a type of thyroid cancer that can no longer be treated with radioactive iodine and is progressing. LENVIMA is used along with another medicine called everolimus to treat adults with a type of kidney cancer called advanced renal cell carcinoma (RCC) after one course of treatment with another anti-cancer medicine. LENVIMA is used by itself as the first treatment for a type of liver cancer called hepatocellular carcinoma (HCC) when it cannot be removed by surgery. LENVIMA is used along with another medicine called pembrolizumab to treat advanced endometrial carcinoma, a type of uterine cancer: that is not microsatellite instability-high (MSI-H) or mismatch repair deficient (dMMR), and that has progressed after treatment with anti-cancer medicine, and that cannot be treated with surgery or radiation. This use |
HTTP/1.1 301 Moved Permanently Content-Length: 147 Content-Type: text/html; charset=UTF-8 Location: https://www.lenvima.com/ Origin: Prod_CD1 Content-Security-Policy: default-src 'unsafe-eval' 'unsafe-inline' * blob:; script-src 'unsafe-inline' 'unsafe-eval' * blob:; img-src * data:; connect-src *; font-src * data:; style-src 'unsafe-inline' *;frame-ancestors 'self' https://medscape.com https://www.medscape.com Strict-Transport-Security: max-age=31536000; includeSubDomains; preload X-Content-Type-Options: nosniff X-XSS-Protection: 1; mode=block X-Frame-Options: SAMEORIGIN Date: Fri, 22 Oct 2021 05:10:25 GMT HTTP/2 200 cache-control: no-cache, no-store pragma: no-cache content-length: 40881 content-type: text/html; charset=utf-8 expires: -1 set-cookie: ASP.NET_SessionId=l4czv3m45w3zvs550ynjenjs; path=/; HttpOnly; SameSite=Lax set-cookie: SC_ANALYTICS_GLOBAL_COOKIE=babedcdfd1f840778bab42989c7b5dcc|False; expires=Mon, 20-Oct-2031 05:10:26 GMT; path=/; HttpOnly set-cookie: sxa_site=Lenvima; path=/ origin: Prod_CD1 content-security-policy: default-src 'unsafe-eval' 'unsafe-inline' * blob:; script-src 'unsafe-inline' 'unsafe-eval' * blob:; img-src * data:; connect-src *; font-src * data:; style-src 'unsafe-inline' *;frame-ancestors 'self' https://medscape.com https://www.medscape.com strict-transport-security: max-age=31536000; includeSubDomains; preload x-content-type-options: nosniff x-xss-protection: 1; mode=block x-frame-options: SAMEORIGIN date: Fri, 22 Oct 2021 05:10:26 GMT |
Domain Name: LENVIMA.COM Registry Domain ID: 1747765967_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.1api.net Registrar URL: http://www.1api.net Updated Date: 2021-08-13T02:36:03Z Creation Date: 2012-09-26T02:08:22Z Registry Expiry Date: 2022-09-26T02:08:22Z Registrar: 1API GmbH Registrar IANA ID: 1387 Registrar Abuse Contact Email: abuse@1api.net Registrar Abuse Contact Phone: +49.68949396850 Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited Name Server: NS1.FSIWEBS.NET Name Server: NS2.FSIWEBS.NET DNSSEC: unsigned >>> Last update of whois database: 2021-09-10T21:47:31Z <<< |